Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study-Reference-Cited by-同舟云学术

Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study

Published:2012-10 Issue:10 Volume:23 Page:2599-2605
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Collea R.P.,Kruter F.W.,Cantrell J.E.,George T.K.,Kruger S.,Favret A.M.,Lindquist D.L.,Melnyk A.M.,Pluenneke R.E.,Shao S.H.,Crockett M.W.,Asmar L.,O’Shaughnessy J.

Funder

This study was supported by funds from Ortho Biotech, LP

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/10/2599/13786184/mds052.pdf

Reference35 articles.

1. Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. Phase II study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation;Christodoulou;Oncology,2009

2. Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study;Adamo;Br J Cancer,2008

3. Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial;Chia;J Clin Oncol,2006

4. Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198;Wolff;Breast Cancer Res Treat,2010

5. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines;Trudeau;J Clin Oncol,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Exosome-based Drug Delivery System in Combination Anticancer Treatment;Journal of Korean Society of Health-System Pharmacists;2023-05-31

2. Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study;Breast Cancer Research and Treatment;2023-03-06

3. Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer;Breast Cancer: Targets and Therapy;2018-09

4. Biodegradable Interlayer-Crosslinked Polymer Micelles with Reduction Sensitivity for Non-Small Cell Lung Cancer Therapy;Journal of Biomedical Nanotechnology;2018-07-01

5. Smart nanoconstructs for theranostics in cancer and cardiovascular diseases;Core-Shell Nanostructures for Drug Delivery and Theranostics;2018